104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

Summary

To observe the long-term treatment with BG9924 when administered to participants with RA who previously participated in a Biogen Idec Study.

Timeline

Start

2007-11

Primary completion

2008-10

Completion

2008-10

Outcome

Outcome not reported

Stopped: “Analysis of data from 104RA202 failed to meet primary endpoint”

Drugs

Indications